SEC Form 4 · accession 0001209191-18-026654
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Hadfield
Officer — General Counsel and Secretary
Period of report
Apr 25, 2018
Accepted (ET)
Apr 27, 2018 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $4.32 | Apr 25, 2018 | A | 150,000 | A | — | Apr 25, 2028 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F150,000 shares shall vest on each of 4/25/2019, 4/25/2020 and 4/25/2021.